New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays
- 1 January 1998
- journal article
- case report
- Published by Wiley in Transfusion
- Vol. 38 (1), 56-59
- https://doi.org/10.1046/j.1537-2995.1998.38198141499.x
Abstract
Envelope mutant forms of hepatitis B virus (HBV), impairing HBV antibody recognition, have been reported with mutations in single or multiple sites of the hepatitis B surface antigen (HBsAg) group-specific "a" determinant. Blood donors infected with such an HBsAg mutant form of HBV may escape detection by HBsAg screening assays and therefore may affect the safety of the blood supply. A repeat blood donor became HBsAg-reactive in an enzyme immunoassay. Confirmatory testing yielded negative results for HBsAg in a radioimmunoassay and in four enzyme immunoassays used in blood donor screening. The specificity of the HBsAg reactivity in the first enzyme immunoassay was confirmed by HBsAg neutralization with antibody to HBsAg. Additional HBV confirmatory test results were positive for antibody to hepatitis B core antigen and antibody to hepatitis B e antigen; negative for antibody to HBsAg and for hepatitis B e antigen; and positive for HBV DNA. DNA sequence analysis of the "a" determinant region of HBsAg revealed amino acid substitutions from Q (Gln) to R (Arg) at codon 129 and from M (Met) to T (Thr) at codon 133. This case illustrates the presence of HBsAg mutant forms of HBV in a West European blood donor population that were undetected by several HBsAg screening assays. Adaptation of HBsAg screening is indicated to overcome deficiencies in sensitivity in detecting HBsAg mutant forms of HBV. Screening for antibody to hepatitis B core antigen or HBV DNA may also detect blood donors infected with HBsAg mutant forms of HBVKeywords
This publication has 14 references indexed in Scilit:
- Report of EPFA/NIBSC Workshop ‘Nucleic Acid Amplification Tests (NAT) for the Detection of Blood‐Borne Viruses’ Held on 31 October 1996 in Amsterdam, The NetherlandsVox Sanguinis, 1997
- The Risk of Transfusion-Transmitted Viral InfectionsNew England Journal of Medicine, 1996
- Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipientsTransfusion, 1995
- Vaccine-associated Mutants of Hepatitis B VirusPublished by Springer Nature ,1994
- Genetic relatedness of hepatitis B viral strains of diverse geographical origin and natural variations in the primary structure of the surface antigenJournal of General Virology, 1993
- Loss of the common "A" determinant of hepatitis B surface antigen by a vaccine-induced escape mutant.Journal of Clinical Investigation, 1992
- Vaccine-induced escape mutant of hepatitis B virusThe Lancet, 1990
- Rapid identification of low level hepatitis B-related viral genome in serum.Journal of Clinical Investigation, 1989
- Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated BloodAnnals of Internal Medicine, 1986
- Hepatitis B Virus DNA in Patients with Chronic Liver Disease and Negative Tests for Hepatitis B Surface AntigenNew England Journal of Medicine, 1985